RU2008122964A - Азитромицин для лечения гранулематозных розовых (красных) угрей - Google Patents

Азитромицин для лечения гранулематозных розовых (красных) угрей Download PDF

Info

Publication number
RU2008122964A
RU2008122964A RU2008122964/14A RU2008122964A RU2008122964A RU 2008122964 A RU2008122964 A RU 2008122964A RU 2008122964/14 A RU2008122964/14 A RU 2008122964/14A RU 2008122964 A RU2008122964 A RU 2008122964A RU 2008122964 A RU2008122964 A RU 2008122964A
Authority
RU
Russia
Prior art keywords
azithromycin
red
granulomatous
blackheads
pink
Prior art date
Application number
RU2008122964/14A
Other languages
English (en)
Russian (ru)
Inventor
Серена МРАЗ-ДЖЕРНХАРД (US)
Серена МРАЗ-ДЖЕРНХАРД
Джеффри ШУГАРМАН (US)
Джеффри ШУГАРМАН
Original Assignee
Дау Фармасьютикал Сайенсиз (Us)
Дау Фармасьютикал Сайенсиз
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дау Фармасьютикал Сайенсиз (Us), Дау Фармасьютикал Сайенсиз filed Critical Дау Фармасьютикал Сайенсиз (Us)
Publication of RU2008122964A publication Critical patent/RU2008122964A/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203Retinoic acids ; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
RU2008122964/14A 2005-11-09 2006-11-08 Азитромицин для лечения гранулематозных розовых (красных) угрей RU2008122964A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73484305P 2005-11-09 2005-11-09
US60/734,843 2005-11-09

Publications (1)

Publication Number Publication Date
RU2008122964A true RU2008122964A (ru) 2009-12-20

Family

ID=38309684

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008122964/14A RU2008122964A (ru) 2005-11-09 2006-11-08 Азитромицин для лечения гранулематозных розовых (красных) угрей

Country Status (10)

Country Link
US (1) US20070105788A1 (https=)
EP (1) EP1945227A4 (https=)
JP (1) JP2009514963A (https=)
CN (1) CN101304750A (https=)
AU (1) AU2006336612A1 (https=)
BR (1) BRPI0617693A2 (https=)
CA (1) CA2626551A1 (https=)
RU (1) RU2008122964A (https=)
WO (1) WO2007086978A2 (https=)
ZA (1) ZA200804896B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2425682C1 (ru) * 2010-04-28 2011-08-10 Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "УрНИИДВиИ Росмедтехнологий") Способ лечения акне средней степени тяжести

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124123B2 (en) * 2007-09-05 2012-02-28 Dow Pharmaceutical Sciences, Inc. Controlled release azithromycin solid dosages forms
US8143227B2 (en) * 2007-09-05 2012-03-27 Dow Pharmaceutical Sciences, Inc. Azithromycin for treatment of skin disorders
MX2010009493A (es) * 2008-02-28 2010-12-20 Rp Scherer Technologies Llc Proceso para minimizar el polimorfismo.
WO2010006306A1 (en) * 2008-07-10 2010-01-14 Inspire Pharmaceuticals, Inc. Method of treating blepharitis
WO2010085572A1 (en) * 2009-01-23 2010-07-29 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with azithromycin
US20130274214A1 (en) * 2010-12-29 2013-10-17 Inspire Pharmaceuticals, Inc. Method for treating blepharitis
JP5986632B2 (ja) 2011-06-28 2016-09-06 メディシス ファーマシューティカル コーポレイション 高用量粘膜接着性メトロニダゾール水系ゲル製剤および細菌性膣炎を治療するためのそれらの使用
WO2014100569A1 (en) * 2012-12-20 2014-06-26 Medicis Pharmaceutical Corporation High dosage topical metronidazole gel formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2446356C (en) * 2001-05-09 2012-07-10 The Regents Of The University Of Michigan Use of compositions for treating rosacea

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2425682C1 (ru) * 2010-04-28 2011-08-10 Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "УрНИИДВиИ Росмедтехнологий") Способ лечения акне средней степени тяжести

Also Published As

Publication number Publication date
JP2009514963A (ja) 2009-04-09
EP1945227A2 (en) 2008-07-23
WO2007086978A2 (en) 2007-08-02
CN101304750A (zh) 2008-11-12
EP1945227A4 (en) 2009-09-30
WO2007086978A3 (en) 2007-11-22
AU2006336612A1 (en) 2007-08-02
CA2626551A1 (en) 2007-08-02
US20070105788A1 (en) 2007-05-10
ZA200804896B (en) 2009-07-29
BRPI0617693A2 (pt) 2011-08-02

Similar Documents

Publication Publication Date Title
Chang et al. Gabapentin in acute postoperative pain management
ATE319457T1 (de) Behandlung iatrogenen und altersbedingten bluthochdruck mit vitamin b6-derivative, und pharmazeutische zusammensetzungen verwendbar dazu
RU2013123646A (ru) Комбинированная композиция
RU2008122964A (ru) Азитромицин для лечения гранулематозных розовых (красных) угрей
NO20080244L (no) Doseringsstyring for prasugrel
RU2009101026A (ru) Применение тимозина-альфа-1 для получения лекарственного средства для лечения злокачественной меланомы на iv стадии
Bavbek et al. Recurrent hyponatremia associated with citalopram and mirtazapine
CN101028337A (zh) 一种用于鼻腔冲洗的盐水液
Liu et al. Intravenous Administration of Vitamin C in the Treatment of Herpes Zoster‐Associated Pain: Two Case Reports and Literature Review
RU2009116629A (ru) Азитромицин для лечения узелковых угрей
RU2010139840A (ru) Комбинация противораковых агентов
Hicks et al. A preliminary dose-ranging trial of proglumide for the treatment of refractory schizophrenics
CN104324018A (zh) 广藿香醇在制备男性性功能障碍药物或保健品中的应用
RU2585097C1 (ru) Способ лечения хронического панкреатита
CN1140271C (zh) 一种治疗眩晕症的药物
AR040113A1 (es) Metodo para producir unidades de dosificacion farmaceuticas para administracion oral, que comprenden etonogestrel
CN101843626A (zh) 一种治疗痤疮的酊剂
RU2351358C2 (ru) Применение lh для лечения отсутствия либидо и достижения оргазма у женщин
RU2106877C1 (ru) Способ лечения идиопатического дерматомиозита
WO2023172148A1 (en) Medication
AR069099A1 (es) Azitromicina para el tratamiento de trastornos cutaneos, formulacion farmaceutica y kit
RU2002128958A (ru) Способ лечения онкологических больных
CN115337315A (zh) 三氮脒在制备治疗肝纤维化药物中的应用
RU2004114005A (ru) Способ лечения алкогольных болезней печени
RU2010145588A (ru) Способ лечения больных грибовидным микозом

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20100818